NOEL SALVOZA

Licensed Physician

1. Salvoza N, Bedin C, Saccani A, Tiribelli C, Rosso N. The Beneficial Effects of Triterpenic Acid and Acteoside in an In Vitro Model of Nonalcoholic Steatohepatitis (NASH). International Journal of Molecular Sciences. 2022; 23(7):3562. https://doi.org/10.3390/ijms23073562 

2. Giraudi PJ, Salvoza N, Bonazza D, Saitta C, Lombardo D, Casagranda B, de Manzini N, Pollicino T, Raimondo G, Tiribelli C, Palmisano S, Rosso N. Ficolin-2 Plasma Levels Assess Liver Fibrosis in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences. 2022; 23(5):2813. https://doi.org/10.3390/ijms23052813

3. Salvoza N, Giraudi PJ, Tiribelli C, Rosso N. Natural Compounds for Counteracting Nonalcoholic Fatty Liver Disease (NAFLD): Advantages and Limitations of the Suggested Candidates. International Journal of Molecular Sciences. 2022; 23(5):2764. https://doi.org/10.3390/ijms23052764

4. Salvoza N, Giraudi Pj, Tiribelli C, Rosso N. Sex Differences in Non-Alcoholic Fatty Liver Disease: Hints For Future Management of the Disease. Explor Med. 2020;1:51–74. DOI: https://Doi.Org/10.37349/Emed.2020.0000 

5. Salvoza N, Klinzing DC, Gopez-Cervantes J, Baclig MO (2016). Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease. PLoS ONE 11(4): e0153497. doi:10.1371/journal.pone.0153497 

6. Kawashima KD, Suarez L-AC, Labayo HKM, Liles VR, Salvoza N, Klinzing DC, Daroy MLG, Matias RR, Natividad FF. (2014). Complete genome sequence of chikungunya virus isolated in the Philippines. American Microbiology Society, Genome Announc. 2(3):e00336-14. doi:10.1128/genomeA.00336-14. 

• “The International Liver Congress 2023” by The European Association for the Study of the Liver (EASL). Vienna, Austria. June 21-24, 2023 (Future Event).
• 2022 World Research and Innovation Festival (A Virtual Conference). Organized by West Visayas State University. October 17-19, 2022.
• European Association For The Study of The Liver (EASL) Basic Science School: “Precision Cut Liver Slices and Liver Organoids – versatile ex-vivo models of liver disease.” London, United Kingdom. September 15-17, 2022.
• “The International Liver Congress 2022” by The European Association for the Study of the Liver (EASL). London, United Kingdom. June 22-26, 2022.
• International Conference on Fatty Liver. Vienna, Austria. February 17-22, 2022.
• Convention on Pharmaceutical Ingredients (CPhI) Worldwide 2021. Milan, Italy. November 09-11, 2021
• Digital NAFLD Summit by The European Association For The Study Of The Liver (EASL). Italy. September 16-17, 2021.
• The Liver Meeting by The American Association for the Study of the Liver Diseases. Digital Platform. November 12-15, 2021.
• “The International Liver Congress 2021” by The European Association for the Study of the Liver (EASL). Italy. June 23-26, 2021.
• Formazione E Training Del Personale Coinvolto Nelle Attivita’ Di Sperimentazione Animale. Università di Trieste
• Corso di Laurea in Medicina e Chirurgia Organismo Preposto al Benessere Animale. May 05, 12, 19, 20, 26, 27, 2021.
• The Pathogenesis of NAFLD: From Genes to Tissue Omics” by Silvia Sookoian. Italian Liver Foundation. April 12, 2021.
• Weight Reduction and its Results: Methods, Metabolism and Implications” by Julie Ingelfinger. Italian Liver Foundation. March 22, 2021.
• Dissecting the Role of beta-Klotho Protein in NAFLD by Anna Alisi. Italian Liver Foundation. March 08, 2021.
• Novelty in Terms Of Applications of Genetics to Hepatic Steatosis” by Luca Valenti. Italian Liver Foundation. February 15, 2021.
• Nitric Oxide, Peroxyntrite and Protein Tyrosine Nitration: Disruption of Redox Pathways in Human Disease by Rafael Radi. Italian Liver Foundation. February 08, 2021.
• Prevention of Bilirubin Neurotoxicity in the Preterm Infant by Cynthia Bearer. Italian Liver Foundation. January 25, 2021.
• Bilirubin is a Fat-Busting Hormone that Improves Metabolic Dysfunction by Terry Hinds. Italian Liver Foundation. January 11, 2021.
• Hyperglucagonemia – A Disrupted Liver-Alpha Cell Crosstalk in Fatty Liver Disease. Mercodia. December 10, 2020.
• Combining HIPSC-Derived Hepatocytes & Bioinformatics – Investigating the Potential to Model Non-Alcoholic Steatohepatitis (NASH). TAKARA. September 17, 2020.
• St. Luke’s Molecular Medicine Society’s Webinar Series, Back to Basics: Benchside Research. "Translational Approach for the Study of Non-Alcoholic Fatty Liver Disease: A Wide Spectrum Disease". Philippines (Via Online Meeting).” October 31, 2020.
• 2018 International Molecular Medicine Conference Forum. Bench to Bedside and Beyond. SLMC-QC, Philippines. November 17-18, 2018
• 6th Association of Philippine Medical Colleges – Student Network. (APMC-SN) Regional Convention. University of St. La Salle, Bacolod City. November 17-18, 2017
• 50th Association of Philippine Medical Colleges – Student Network. (APMC-SN) National Convention. Ateneo School of Medicine and Public Health, Pasig City. February 1-3, 201710th Philippine National Health Research System Week. “Research and Innovation for Health and Environment”
• Palawan, Philippines. August 11-12, 2016

• The potential role of Omentin-1 in Metabolic Associated Fatty Liver Disease (MAFLD): evidence from translational studies. “The International Liver Congress” by The European Association for the Study of the Liver (EASL). Vienna, Austria. June 21-24, 2023 (Future Event). Poster Presenter.
• In silico identification and validation of plasma Ficolin-2 (FCN-2) as non-invasive biomarker of fibrosis in Non-alcoholic Fatty Liver Disease (NAFLD). “The International Liver Congress” by The European Association for the Study of the Liver (EASL). London, United Kingdom. June 22-26, 2022. Poster Presenter.
• Anti-oxidant, Anti-inflammatory, and Anti-fibrotic Properties of Triterpenic Acid and Acteoside in In Vitro Models of Non-Alcoholic Steatohepatitis (NASH). “International Conference on Fatty Liver”. Vienna, Austria. February 17-22, 2022. Poster Presenter.
• Anti-oxidant, Anti-inflammatory, and Anti-fibrotic Properties of Triterpenic Acids ABRTA22 (TA) and Phenylpropanoids ABRPP09 (PP) in In Vitro Models of Non-Alcoholic Steatohepatitis. “Digital NAFLD Summit” by the European Association for the Study of the Liver (EASL). Italy. September 16-17, 2021. Poster Presenter.
• Alternative Compounds to Nonalcoholic Steatohepatitis (NASH) Treatment: In Vitro Evidence of Triterpenic Acids and Phenylpropanoids" “The Liver Meeting” by The American Association for the Study of the Liver Diseases. Digital Platform. November 12-15, 2021. Poster Presenter.
• Anti-oxidant, Anti-Inflammatory, and Anti-fibrotic Properties of Triterpenic Acids ABRTA22 (TA) and Phenylpropanoids ABRPP09 (PP) in In Vitro Models of Non-Alcoholic Steatohepatitis. “The International Liver Congress” by The European Association for the Study of the Liver (EASL). Italy. June 23-26, 2021. Poster Presenter.
• Clinico-Laboratory Profiles and Development of a Simple Predictor in Differentiating Dengue from Other Febrile Illnesses (OFI) in Western Visayas Medical Center: A Retrospective Study from 2014-2016. 51st APMC-SN National Convention. PLM, Manila. February 07, 2018. First Place, Poster Presentation
• In Vitro Evaluation of Antibacterial and Anti-cancer Activities of Aqueous, Butanol, and Chloroform Fractions of Durian (Durio zibethinus) Rind Methanolic Extracts. ASMPH, Pasig City. February 2, 2017. National Finalist, Oral Presentation
• “In Vitro Evaluation of Anti-staphylococcal, Anti-Cervical Adenocarcinoma, and Anti-Hepatocelluar Carcinoma Activities of Aqueous, Butanol, and Chloroform Fractions of Durian Rind Methanolic Extracts”. 10th Philippine National Health Research System Week. Puerto Princesa City, Palawan. August 11, 2016. Poster Presenter, First Place.
• “Evaluation of Serum MicroRNAs as Potential Biomarkers for Filipino Patients with Chronic Hepatitis B and Non-Alcoholic Fatty Liver Disease” First PCHRD Scholars’ Society Research Forum. Makati City. March 17, 2016. Oral Presenter

• Winner of Highly Cited Paper Award 2021–2022 ‘Exploration of Medicine’ 2022
• Winner of Highly Cited Paper Award 2020–2021 ‘Exploration of Medicine’ 2021
• Department of Science & Technology (DOST-PCHRD) – PhD Scholar 2019-present
• St Luke’s Molecular Medicine Society - Member 2016-present
• PCHRD Scholars Society – Member 2015-present
• Asian Medical Students’ Association – Member 2014-2018
• Association of Philippine Medical Colleges, Student Network – Member 2014-2018
• Department of Science & Technology (DOST-PCHRD) – MS Scholar 2010-2012
• University of the Philippines Biological Society – Member 2006-2010
• University of the Philippines Amphiprion Society – Member 2006-2010

1. Translational Approach for the Study of Non-Alcoholic Fatty Liver Disease (NAFLD):  A Wide Spectrum Disease (Fondazione Italiana Fegato – Italy). 2019 - Present 

2. Comprehensive study on virus quasi-species and vascular permeability factors in severe dengue infection in humans for innovative epidemic and clinical managements:

e-ASIA Japan, Vietnam, Philippines Research Project. (Molecular Immunology Laboratory – R&B, SLMC). 2014 – 2016 

3. Serotyping of Dengue Virus Isolated in the Philippines. (Molecular Immunology Laboratory – R&B, SLMC).  2012 – 2014

4. Chikungunya Virus Research. (Molecular Immunology Laboratory – R&B, SLMC). 2012 – 2014

5. Identification, Characterization and Evaluation of Anti- Dengue Activity in Selected Philippine Plants (R&B, SLMC). 2010-2014.